These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6704042)

  • 1. Ototoxic effect of erythromycin therapy.
    Schweitzer VG; Olson NR
    Arch Otolaryngol; 1984 Apr; 110(4):258-60. PubMed ID: 6704042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythromycin associated hearing loss in a patient with prior cis-platinum induced ototoxicity.
    Wallach PM; Love SR; Fiorica JV; Hoffman MS; Flannery MT
    J Fla Med Assoc; 1992 Dec; 79(12):821-2. PubMed ID: 1474367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythromycin ototoxicity.
    Thompson P; Wood RP; Bergstrom L
    J Otolaryngol; 1980 Feb; 9(1):60-2. PubMed ID: 7359612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irreversible ototoxic effect of erythromycin.
    Levin G; Behrenth E
    Scand Audiol; 1986; 15(1):41-2. PubMed ID: 3704541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythromycin ototoxicity: a call to heighten recognition.
    Whitener CJ; Parker JE; Lapp NL
    South Med J; 1991 Oct; 84(10):1214-6. PubMed ID: 1925722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythromycin ototoxicity: analysis and conclusions based on 22 case reports.
    Haydon RC; Thelin JW; Davis WE
    Otolaryngol Head Neck Surg; 1984 Dec; 92(6):678-84. PubMed ID: 6440087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ototoxic reaction to erythromycin.
    Agustí C; Ferrán F; Gea J; Picado C
    Arch Intern Med; 1991 Feb; 151(2):380. PubMed ID: 1992966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythromycin ototoxicity and acute psychotic reaction in cancer patients with hepatic dysfunction.
    Umstead GS; Neumann KH
    Arch Intern Med; 1986 May; 146(5):897-9. PubMed ID: 3963982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythromycin ototoxicity: prospective assessment with serum concentrations and audiograms in a study of patients with pneumonia.
    Swanson DJ; Sung RJ; Fine MJ; Orloff JJ; Chu SY; Yu VL
    Am J Med; 1992 Jan; 92(1):61-8. PubMed ID: 1731511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythromycin-induced ototoxicity substantiated by rechallenge.
    Schwartz JI; Maggini GA
    Clin Pharm; 1982; 1(4):374-6. PubMed ID: 7185536
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cochlear toxicity of erythromycin in elderly patients].
    Hugues FC; Laccourreye A; Lasserre MH; Toupet M
    Therapie; 1984; 39(5):591-4. PubMed ID: 6506017
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical perspectives on ototoxic drugs.
    Matz GJ
    Ann Otol Rhinol Laryngol Suppl; 1990 Jun; 148():39-41. PubMed ID: 2112362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Reversible hearing loss and erythromycin].
    Rydberg J
    Lakartidningen; 1984 Mar; 81(13):1308. PubMed ID: 6708672
    [No Abstract]   [Full Text] [Related]  

  • 14. Irreversible sensorineural hearing loss due to erythromycin.
    Dylewski J
    CMAJ; 1988 Aug; 139(3):230-1. PubMed ID: 3395937
    [No Abstract]   [Full Text] [Related]  

  • 15. Sensorineural hearing loss with low dose erythromycin.
    Kemp E; Keidar S; Brook JG
    BMJ; 1991 Jun; 302(6788):1341. PubMed ID: 2059706
    [No Abstract]   [Full Text] [Related]  

  • 16. Experimental, clinical and preventive aspects of ototoxicity.
    Chiodo AA; Alberti PW
    Eur Arch Otorhinolaryngol; 1994; 251(7):375-92. PubMed ID: 7857625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversible sensorineural hearing loss with intravenous erythromycin lactobionate.
    Karmody CS; Weinstein L
    Ann Otol Rhinol Laryngol; 1977; 86(1 Pt 1):9-11. PubMed ID: 835977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ototoxic potential of erythromycin].
    Demaldent JE; Rolland A; Mongrolle Y
    Ann Otolaryngol Chir Cervicofac; 1984; 101(8):643-7. PubMed ID: 6534259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ototoxicity of deferoxamine].
    de España R; Biurrun O; Lorente J; Valls J; Orteu N; Traserra J
    An Otorrinolaringol Ibero Am; 1992; 19(4):341-7. PubMed ID: 1636908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quinine-induced hearing loss.
    Nielsen-Abbring FW; Perenboom RM; van der Hulst RJ
    ORL J Otorhinolaryngol Relat Spec; 1990; 52(1):65-8. PubMed ID: 2406680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.